Actualités Numinus Wellness Inc - NUMI | Actions Toronto Stock Exchange

Numinus Announces Partnership with MAPS to Support Therapist Psychedelic Experiential Training

Numinus Announces Partnership with MAPS to Support Therapist Psychedelic Experiential Training PR Newswire VANCOUVER, BC, June 15, 2023 Numinus...

Numinus Appoints New Chief Financial Officer

Numinus Appoints New Chief Financial Officer PR Newswire VANCOUVER, BC, June 14, 2023 VANCOUVER, BC, June 14, 2023 /PRNewswire/ - Numinus...

Numinus to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on June 20-22, 2023

Numinus to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on June 20-22, 2023 PR...

Cedar Clinical Research, by Numinus, the top enrolling clinical research site for MindMed's Phase 2B study evaluating MM-120

Cedar Clinical Research, by Numinus, the top enrolling clinical research site for MindMed's Phase 2B study evaluating MM-120 PR...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Numinus Wellness Inc (NUMI)

Outils de qualité professionnelle, pour des investisseurs individuels.

NUMI Actualités

Numinus Announces Partnership with MAPS to Support Therapist Psychedelic Experiential Training

Numinus Appoints New Chief Financial Officer

Numinus to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on June 20-22, 2023

Cedar Clinical Research, by Numinus, the top enrolling clinical research site for MindMed's Phase 2B study evaluating MM-120

Numinus to Participate in a Water Tower Research Fireside Chat on Wednesday, June 7, 2023

Numinus to research COMP360 psilocybin therapy in treatment-resistant depression as part of large phase 3 study

Numinus Aligns Business Initiatives to Prepare for Future Approval of MDMA-Assisted Therapy

Numinus to Participate in a Water Tower Research Fireside Chat on Wednesday, April 19, 2023

Numinus Launches New Website to Enhance its Client Experience

Numinus Wellness Inc. Reports Q2 2023 Results

Numinus Launches new Clinic Licensing Platform, the Numinus Network, to Accelerate Expansion

Numinus to Host Q2 2023 Results Conference Call on April 13, 2023

Numinus Launches the Practitioner Certification Pathway - a Complete Psychedelic-Assisted Therapy Training Program

Numinus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023

Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Numinus Wellness Inc (NUMI) Actualités

Numinus Wellness Inc (NUMI)

Outils de qualité professionnelle, pour des investisseurs individuels.

NUMI Actualités

Numinus Announces Partnership with MAPS to Support Therapist Psychedelic Experiential Training

Numinus Appoints New Chief Financial Officer

Numinus to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on June 20-22, 2023

Cedar Clinical Research, by Numinus, the top enrolling clinical research site for MindMed's Phase 2B study evaluating MM-120

Numinus to Participate in a Water Tower Research Fireside Chat on Wednesday, June 7, 2023

Numinus to research COMP360 psilocybin therapy in treatment-resistant depression as part of large phase 3 study

Numinus Aligns Business Initiatives to Prepare for Future Approval of MDMA-Assisted Therapy

Numinus to Participate in a Water Tower Research Fireside Chat on Wednesday, April 19, 2023

Numinus Launches New Website to Enhance its Client Experience

Numinus Wellness Inc. Reports Q2 2023 Results

Numinus Launches new Clinic Licensing Platform, the Numinus Network, to Accelerate Expansion

Numinus to Host Q2 2023 Results Conference Call on April 13, 2023

Numinus Launches the Practitioner Certification Pathway - a Complete Psychedelic-Assisted Therapy Training Program

Numinus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023

Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités